← brief for 2026-10-16 · Slowing decline

Real-World Anthropometric Outcomes, Safety, and Use Patterns of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Obesity and Glucose Metabolism Disorder: A Nationwide Multicentre Community Pharmacy Study

Article No results yet Peer reviewed

Key takeaways

This study looks at weight-loss drugs in real-world settings. It may help people with kidney disease manage their weight. There is no abstract, so no results are available yet.

Who did this work

Vergniory-Trueba O (Pharmaceutical Care España Foundation, 08009 Barcelona, Spain) · Treceño-Lobato C (Pharmaceutical Care España Foundation, 08009 Barcelona, Spain)

Source

Article · Europe PMC, CKD mind-body · 2026-10-01
https://europepmc.org/article/PMC/PMC13665570